Fatal acute haemopericardium associated with rivaroxaban in a patient with non-valvular atrial fibrillation

被引:0
|
作者
Omer, Siddiq [1 ]
Magezi, Frederick [2 ]
Patel, Martyn [3 ]
Alsawaf, Ali [4 ]
机构
[1] James Paget Univ Hosp, ST4 Geriatr, Great Yarmouth, England
[2] Queen Elizabeth Hosp, ST4 Geriatr, Kings Lynn, England
[3] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England
[4] Queen Elizabeth Hosp, Kings Lynn, England
关键词
Rivaroxiban; Haemopericardium; Fatal; Older people;
D O I
10.1093/ageing/afz070
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
An 82-year-old female was admitted with chest pain and non-specific T wave changes on her ECG. After 72 hours of conservative management she deteriorated with non-specific symptoms including nausea and a single episode of vomiting. Abdominal and Chest X-rays were unremarkable, blood tests showed worsening Acute Kidney Injury (AKI) on Chronic Kidney Disease (CKD); and raised C-Reactive Protein (CRP) with no obvious symptoms or focus of infection. She rapidly deteriorated going into asystole cardiac arrest and attempts at resuscitation failed. Post-mortem examination suggested the most likely cause of death was acute spontaneous Haemopericardium due to Rivaroxaban therapy which she was on for non-valvular Atrial Fibrillation (AF). We believe that this might be the first reported mortality with Rivaroxaban-associated spontaneous haemopericardium in the UK.
引用
收藏
页码:758 / 760
页数:3
相关论文
共 50 条
  • [1] Rivaroxaban is associated with higher risk of acute kidney disease in patients with non-valvular atrial fibrillation
    Li, Wen
    Meng, Jiali
    Dong, Xingtong
    Zhang, Jinhui
    Cui, Xiaohui
    Jia, Qiang
    Fu, Wenjing
    Jia, Linpei
    Zhang, Aihua
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 15 (11): : 402 - 408
  • [2] Breakthrough Stroke During Rivaroxaban Therapy in a Patient with Non-Valvular Atrial Fibrillation
    Ahn, Inhye E.
    Kim, Myungsun
    [J]. BLOOD, 2012, 120 (21)
  • [3] Rivaroxaban in Non-Valvular Atrial Fibrillation: a Prospective Studies and Clinical Practice
    Fonyakin, A. V.
    [J]. KARDIOLOGIYA, 2016, 56 (08) : 87 - 92
  • [4] RIVAROXABAN IN PREVENTION OF STROKE IN ELDERLY PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Yavelov, I. S.
    [J]. KARDIOLOGIYA, 2019, 59 (12) : 4 - 11
  • [5] Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban
    Breithardt, Guenter
    Baumgartner, Helmut
    Berkowitz, Scott D.
    Hellkamp, Anne S.
    Piccini, Jonathan P.
    Lokhnygina, Yuliya
    Halperin, Jonathan L.
    Singer, Daniel E.
    Hankey, Graeme J.
    Hacke, Werner
    Becker, Richard C.
    Nessel, Christopher C.
    Mahaffey, Kenneth W.
    Califf, Robert M.
    Fox, Keith A. A.
    Patel, Manesh R.
    [J]. HEART, 2016, 102 (13) : 1036 - 1043
  • [6] Rivaroxaban for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation and Active Cancer
    Laube, Eva Simona
    Yu, Anthony
    Gupta, Dipti
    Miao, Yimei
    Samedy, Patrick
    Wills, Jonathan
    Harnicar, Stephen J.
    Soff, Gerald A.
    Mantha, Simon
    [J]. BLOOD, 2016, 128 (22)
  • [7] Is rivaroxaban associated with lower inpatient costs compared to warfarin among patients with non-valvular atrial fibrillation?
    Laliberte, Francois
    Pilon, Dominic
    Raut, Monika K.
    Nelson, Winnie W.
    Olson, William H.
    Germain, Guillaume
    Schein, Jeff R.
    Lefebvre, Patrick
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (08) : 1521 - 1528
  • [8] FACTORS ASSOCIATED WITH BLEEDING EVENTS IN PATIENTS ON RIVAROXABAN FOR NON-VALVULAR ATRIAL FIBRILLATION: A REAL WORLD EXPERIENCE
    Akhtar, Tauseef
    Mattumpuram, Jishanth
    Fugar, Setri
    Ranka, Sagar
    Fratti, Juan Del Cid
    Mann, Hashim
    Uprety, Alok
    Putta, Aakash
    Golzar, Yasmeen
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 471 - 471
  • [9] Patient with non-valvular atrial fibrillation on ineffective anticoagulant therapy
    Kot, Anna
    Starzyk, Katarzyna
    Dobaj, Lukasz
    Bakowski, Dawid
    Wozakowska-Kaplon, Beata
    [J]. KARDIOLOGIA POLSKA, 2016, 74 : 52 - 54
  • [10] Warfarin in non-valvular atrial fibrillation
    Dalby, A. J.
    Wessels, P.
    Opie, L. H.
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2013, 103 (12): : 901 - 904